Clinical study of outcome of operative management of locally advanced breast carcinoma after neoadjuvant chemotherapy at tertiary care hospital
Keywords:Breast, Carcinoma, Locally advanced carcinoma, Management of breast cancer
Background: Locally advanced diseased of the breast is characterised clinically by features suggesting infiltration of the skin or chest wall by tumour or matted involved axillary nodes (AJCC-stage III). Successful reduction in the size of the tumor is associated with increased rate of operability i.e., modified radical mastectomy or breast conserving therapy (BCT). The aim of this study is to assess outcome of surgery in management of locally advanced breast carcinoma (LABC) after neoadjuvant chemotherapy.
Methods: It is an observational retrospective study of 40 cases of LABC admitted at general surgery department.
Results: The response to neoadjuvant chemotherapy was seen in 92.5% cases- with complete response in 10% cases (4 patients) and partial response in 82.5% (33 patients). No response was observed in 7.5% cases (3 patients) after 4 cycles of neoadjuvant chemotherapy. All patients were subjected to surgery after chemotherapy, out of whom 02 patients (5%) have surgical site infection and flap necrosis in 01 patient (2.5%) and no mortality; 02 patients subjected to toilet mastectomy without neoadjuvant chemotherapy resulted in 01 recurrence within 6 months of completion of adjuvant therapy and 01 death postoperatively.
Conclusions: Majority of patients were subjected to neoadjuvant chemotherapy responded partially to it. Overall observations suggested that most of the LABC responds to neoadjuvant chemotherapy with minimum post-operative morbidity and mortality.
Courtney M. Townsend Jr. MD. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 2012;326-9.
Brunicardi C. Schwartz's Principles of Surgery 10th edition. 2014;129-32.
ICR Network. Risk Factors for Breast Cancer in India: an INDOX Case-Control Study. Indox Cancer Research Network, 2011. Available at: http://www.indox.org.uk/research/epidemiology/casecontrol/breastcancer.html. Accessed on 01 August, 2021.
Williams N. Bailey and Love's Short Practice of Surgery, 26th edition, CRC Press. 2013;63-7.
Pherson MC. Breast cancer-epidemiology, risk factors, and genetics. Bri Med J. 1994;309:1003-6.
Chen AM, Meric-Bernstam F, Hunt KK. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol. 2004;22:2303-12.
Arimappamagan A. Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla? Ind J Cancer. 2004;1(41):13-7.
Brito RA. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 2001;3(19):628-33.
Tapesh B. Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience. Ind J Med Paediatr Oncol. 2014;35(3):215-20.
Deo SVS. Randomized Trial Comparing Neo-Adjuvant Versus Adjuvant Chemotherapy in Locally Advvanced Carcinoma Breast. J Surgical Oncol. 2003;84:192-7.